Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Coherus Biosciences, Inc.
Industry Biopharmaceutical
Founded 2010
Headquarters Redwood City, California, United States
Key people
Dennis M. Lanfear (President, CEO & Chairman)
Website www.coherus.com

Coherus BioSciences is an American biopharmaceutical company focused on developing and commercializing biosimilar drugs.

Coherus BioSciences was founded in 2010 as a pure-play biosimilar company with headquarters in Redwood City, California. The company is publicly traded on the NASDAQ Stock Market with the tag NASDAQ:CHRS.

Coherus develops a type of biologic products called biosimilars.

2016 - Deloitte’s Technology Fast 500 award

Investment goal date:
Dividends reinvested
Coherus Biosciences, Inc. CHRS report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-09
--
--
Q4 2017
2018-03-12
--
--
Q3 2017
2017-11-06
--
--
Q3 2017
2017-11-06
-1.0900
0.0000
Q2 2017
2017-08-07
-1.0800
-1.0800
Q1 2017
2017-05-08
-1.5400
-1.5400
Q4 2016
2017-03-13
-1.7100
-1.7100
Q3 2016
2016-11-09
1.6700
1.6700
Q2 2016
2016-08-09
-1.7200
-1.7200
Q1 2016
2016-05-09
-1.6700
-1.6700
Q4 2015
2016-02-29
-1.3500
-1.3500
Q3 2015
2015-11-09
0.0000
-1.8600
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
1559843
BlackRock Inc.
2844827
BlackRock Institutional Trust Company, N.A.
740118
CARLSON CAPITAL L P
1206801
FMR LLC
7671981
JHL Capital Group LLC
700000
JPMORGAN CHASE & CO
1630487
Kohlberg Kravis Roberts & Co. L.P.
3055055
ORBIMED ADVISORS LLC
1084400
Partner Fund Management, L.P.
1499682
PRICE T ROWE ASSOCIATES INC /MD/
806346
STATE STREET CORP
1117586
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC
900317
Vanguard Group, Inc
2209244
WELLINGTON MANAGEMENT CO LLP
1268479
Major Shareholders
Name Relationship
Total Shares
Holding stocks